Is hyperhomocysteinaemia a minor risk factor for venous thrombosis or subject to publication bias?
Tichelaar, Y.I.G.V.; Lijfering, W.M.
Netherlands Journal of Medicine 73(8): 394-395
2015
ISSN/ISBN: 0300-2977 PMID: 26478558 Document Number: 679058
Document emailed within 1 workday
Related Documents
Mäkelburg, A.B.U.; Lijfering, W.M.; Middeldorp, S.; Hamulyák, K.; Veeger, N.J.G.M.; Prins, M.H.; Büller, H.R.; van der Meer, J. 2009: Low absolute risk of venous and arterial thrombosis in hyperhomocysteinaemia - a prospective family cohort study in asymptomatic subjects Thrombosis and Haemostasis 101(1): 209-212Martinelli, I.; Landi, G.; Merati, G.; Cella, R.; Tosetto, A.; Mannucci, P.M. 1996: Factor V gene mutation is a risk factor for cerebral venous thrombosis Thrombosis and Haemostasis 75(3): 393-394
Dahlbäck, B. 1997: Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis Thrombosis and Haemostasis 78(1): 483-488
Willems, H.P.; den Heijer, M.; Blom, H.J.; Gerrits, W.B.; Rosendaal, F.R.; Bos, G.M. 1999: Hyperhomocysteinemia as a risk factor for venous thrombosis Nederlands Tijdschrift Voor Geneeskunde 143(11): 552-556
Alessandrello Liotta, A.; Marcucci, R.; Bialek, W.; Poli, D.; Ilari, I.; Fedi, S.; Cellai, A.P.; Rogolino, A.; Prisco, D.; Abbate, R. 1999: Lp(a): a new risk factor for deep venous thrombosis? Minerva Cardioangiologica 47(12): 529
Castaman, G.; Faioni, E.M.; Tosetto, A.; Bernardi, F. 2003: The factor V HR2 haplotype and the risk of venous thrombosis: a meta-analysis Haematologica 88(10): 1182-1189
Schlosser, U.; Lackner, K.J.; Scheckenhofer, C.; Spannagl, M.; Spengel, F.A.; Hahn, G.; Lang, B.; Schmitz, G. 1997: Autoantibodies against the protease inhibitor calpastatin: a new risk factor for venous thrombosis? Thrombosis and Haemostasis 77(1): 11-13
Minnee, R.C.; Middeldorp, S.; Legemate, D.A. 2009: Malformation of the V. cava inferior, a risk factor for deep venous thrombosis Nederlands Tijdschrift Voor Geneeskunde 153(11): 496-500
Koopman, K.; Uyttenboogaart, M.; Vroomen, P.C.A.J.; van der Meer, J.; De Keyser, J.; Luijckx, G-Jan. 2009: Risk factors for cerebral venous thrombosis and deep venous thrombosis in patients aged between 15 and 50 years Thrombosis and haemostasis 102(4): 620-622
Saadatnia, M.; Naghavi, N.; Fatehi, F.; Zare, M.; Tajmirriahi, M. 2012: Oral contraceptive misuse as a risk factor for cerebral venous and sinus thrombosis Journal of Research in Medical Sciences: the Official Journal of Isfahan University of Medical Sciences 17(4): 344-347
Reuner, K.H.; Ruf, A.; Grau, A.; Rickmann, H.; Stolz, E.; Jüttler, E.; Druschky, K.F.; Patscheke, H. 1998: Prothrombin gene G20210-->A transition is a risk factor for cerebral venous thrombosis Stroke 29(9): 1765-1769
Kapur, R.; Stramrood, C.A.I.; Schutgens, R.E.G.; van Asbeck, B.Sweder. 2009: Cyproterone acetate- and ethinyloestradiol-containing oral contraceptive as a risk factor for upper extremity deep venous thrombosis-a case report European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 14(2): 160-163
Kleesiek, K.; Schmidt, M.; Götting, C.; Schwenz, B.; Lange, S.; Müller-Berghaus, G.; Brinkmann, T.; Prohaska, W. 1999: The 536C-->T transition in the human tissue factor pathway inhibitor (TFPI) gene is statistically associated with a higher risk for venous thrombosis Thrombosis and Haemostasis 82(1): 1-5
Sharma, S.K.; Gupta, V.; Kadhiravan, T.; Banga, A.; Seith, A.; Kumar, A.; Saxena, R.; Thabah, M.M.; Gulati, V.; Bhatia, I.; Kavimandan, A.A. 2009: A prospective study of risk factor profile and incidence of deep venous thrombosis among medically-ill hospitalized patients at a tertiary care hospital in northern India Indian Journal of Medical Research 130(6): 726-730
Rosendaal, F.R. 1997: Thrombosis in the young: epidemiology and risk factors. a focus on venous thrombosis Thrombosis and Haemostasis 78(1): 1-6
Horbach, D.A.; van Oort, E.; Donders, R.C.; Derksen, R.H.; de Groot, P.G. 1996: Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies Thrombosis and Haemostasis 76(6): 916-924
Keränen, T.; Ylitalo, P. 1999: Publication bias in the clinical drug research Duodecim; Laaketieteellinen Aikakauskirja 115(17): 1828-1832
Rosendaal, F.R. 1997: Risk factors for venous thrombosis: prevalence, risk, and interaction Seminars in Hematology 34(3): 171-187
Medrano, V.; Mallada-Frechín, J.; Fernández-Izquierdo, S.; Piqueras-Rodríguez, L. 2006: Cerebral venous thrombosis and factor V Leiden Revista de Neurologia 43(1): 49-50
Prountjos, P.; Bastounis, E.; Hadjinikolaou, L.; Felekuras, E.; Balas, P. 1991: Superficial venous thrombosis of the lower extremities co-existing with deep venous thrombosis. a phlebographic study on 57 cases International Angiology: a Journal of the International Union of Angiology 10(2): 63-65